China's Changjiang 1 enters commercial operation

Wednesday, 30 December 2015
Changjiang units 1 and 2 - 48Unit 1 of the Changjiang nuclear power plant on China's southern island province of Hainan has entered commercial operation, China National Nuclear Corporation announced on 25 December. The 650 MWe CNP-600 pressurized water reactor was connected to the electricity grid on 7 November.

Unit 1 of the Changjiang nuclear power plant on China's southern island province of Hainan has entered commercial operation, China National Nuclear Corporation (CNNC) announced on 25 December. The 650 MWe CNP-600 pressurized water reactor was connected to the electricity grid on 7 November. 

Changjiang units 1 and 2 - 460 (CNI23)
Changjiang units 1 and 2 (Image: CNNC)

Initial approval for the Changjiang plant's construction was granted by China's National Developmental and Reform Commission in July 2008. Early site works began in December that year. Construction of unit 1 began with the pouring of first concrete on 25 April 2010, while that for unit 2 was poured on 21 November that year.

The loading of the 121 fuel assemblies into the core of Changjiang 1 began on 26 August and the reactor achieved first criticality on 12 October. It is expected to begin commercial operation by the end of this year, while unit 2 is set to start up next year.

The plant, near Hoi Mei Tong village, is being built as a joint venture between CNNC and China Huaneng Group, with shares split 51% and 49%, respectively. The plant will eventually comprise four units, with units 3 and 4 housing either CNP-650 or ACP-600 reactors. Construction of both those units is scheduled to begin by 2018.

CNNC said on 25 December that the two units will together provide one-third of the electricity needs of Hainan. By using nuclear power instead of coal-fired generation, the units will avoid the emission of about 7.8 million tonnes of carbon dioxide, it added.

Researched and written
by World Nuclear News

Related Topics
Related Links
Related Stories
Keep me informed